Sep 09, 2019 / 03:05PM GMT
Jeff Hung - Morgan Stanley, Research Division - Equity Analyst
Welcome to the healthcare conference. I'm Jeff Hung one of the biotech analysts. Before we start, please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at www.morganstanley.com/research disclosures, or at the registration desk. For this session, we have from Theravance Biopharma, Rick Winningham, CEO; Andrew Hindman, CFO; and Brett Haumann, CMO. Welcome.
Rick E. Winningham - Theravance Biopharma, Inc. - Chairman & CEO
Thank you. Thank you. Glad to be here.
Questions and Answers:
Jeff Hung - Morgan Stanley, Research Division - Equity AnalystSo as of this morning -- as this morning showed, the 12 to 16 months are going to be data-rich free-er companies, so we have a lot of ground to cover. But maybe first, for those who are in the room who are not as familiar with